|
OMIM |
Link |
Information gain |
01 |
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
0.0012039
|
|
|
PCOS1
|
[NCBI]
|
0.000755546
|
|
|
PRL
|
[NCBI]
|
0.000678853
|
|
|
SHBG
|
[NCBI]
|
0.000147332
|
|
|
MAS
|
[NCBI]
|
0.000145191
|
|
|
hermaphroditism, true
|
[NCBI]
|
0.000106384
|
|
|
GNRH1
|
[NCBI]
|
9.63624e-05
|
|
|
DRD
|
[NCBI]
|
8.4431e-05
|
|
|
musical perfect pitch
|
[NCBI]
|
8.04338e-05
|
|
|
FMF
|
[NCBI]
|
7.8736e-05
|
|
|
HAE
|
[NCBI]
|
7.2255e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
7.17827e-05
|
|
|
APOD
|
[NCBI]
|
6.20331e-05
|
|
|
PAEP
|
[NCBI]
|
5.554e-05
|
|
|
PXE
|
[NCBI]
|
4.82909e-05
|
|
|
PGR
|
[NCBI]
|
4.81708e-05
|
|
|
SLE
|
[NCBI]
|
4.46485e-05
|
|
|
HOXA10
|
[NCBI]
|
2.53017e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
2.16439e-05
|
|
|
SERPINA6
|
[NCBI]
|
2.13698e-05
|
|
|
PI3
|
[NCBI]
|
2.10689e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.04087e-05
|
|
|
F3
|
[NCBI]
|
1.9707e-05
|
|
|
FMO3
|
[NCBI]
|
1.81266e-05
|
|
|
TFPI2
|
[NCBI]
|
1.54241e-05
|
|
|
EGF
|
[NCBI]
|
1.52179e-05
|
|
|
RA
|
[NCBI]
|
1.51146e-05
|
|
|
MMP2
|
[NCBI]
|
1.466e-05
|
|
|
HRG
|
[NCBI]
|
1.32491e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.31804e-05
|
|
|
MG
|
[NCBI]
|
1.22685e-05
|
|
|
COMT
|
[NCBI]
|
1.11976e-05
|
|
|
BGLAP
|
[NCBI]
|
9.9112e-06
|
|
|
ABP1
|
[NCBI]
|
9.25587e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
8.39726e-06
|
|
|
AMH
|
[NCBI]
|
6.63026e-06
|
|
|
PI
|
[NCBI]
|
6.34315e-06
|
|
|
VEGF
|
[NCBI]
|
6.24656e-06
|
|
|
MB
|
[NCBI]
|
4.25377e-06
|
|
|
EGFR
|
[NCBI]
|
2.28811e-06
|
|
|
TG
|
[NCBI]
|
9.67001e-07
|
|
|
CRH
|
[NCBI]
|
6.45034e-07
|
|
|
CCK
|
[NCBI]
|
5.85626e-07
|
|
|
CEACAM5
|
[NCBI]
|
4.57734e-07
|
|
|
VDR
|
[NCBI]
|
3.77454e-07
|
|
|
VIP
|
[NCBI]
|
3.65154e-07
|
|
|
PTH
|
[NCBI]
|
1.40668e-07
|
|
|
AVP
|
[NCBI]
|
1.20521e-07
|
|
|
HGF
|
[NCBI]
|
7.17916e-08
|
|
|
AFP
|
[NCBI]
|
5.17049e-08
|
|
|
LPL
|
[NCBI]
|
6.61144e-11
|
|